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Introduction
While sensitivity to low levels of chemical exposures is not
a new problem, it has been approached with renewed inter-
est. and controversy, in the last decade. first in North Amer-
ica and more recently in Europe. The Canadian government
first examined the problem of chemical hyper-reactivity in
1985 in its Thomson Report (Thomson 1985) and has since
sponsored several workshops to help define a research
agenda in this area. In the United States, the issue has been
discussed and examined by state governments (Ashford and
Miller 1989: Bascom 1989), federal agencies. (ATSDR
1994). the National Academy of Sciences (NRC 1992), and
a number of professional organizations through workshops.
conferences. and position papers (AOEC 1992: ACP 1989;
AMA 1992). Chemical hyper-reactivity continues to engen-
der scientific debate and controversy around issues relating
to etiology. diagnosis. and treatment. While an increasing
number of patients voice their concern and dissatisfaction
with the response of the medical community and govern-
ment to their illnesses which they believe are caused by ex-
posure to low levels of chemicals in their environments, the
scientific debate rages on: and the medical community con-
tinues to engage in sometimes acrimonious discussions
about the nature of the problem.
Since our overview of the problem in North America
(Ashford and Miller 1991). we are increasingly persuaded
that low-level chemical sensitivity, rather than a clearly-
defined disease entity, might be more correctly described
as a class of disorders-like infectious disease-the mem-
bers of which may present with similar symptoms. but
which have a myriad of precipitating agents and patho-
physiological pathways. Chemical sensitivity may be
viewed as the consequence of a variety of disease pro-
cesses, while "toxin-induced loss of tolerance" may pro-
vide a phenomenological description of those processes,
(Miller 1995a).
In our continued thinking about the problem, we have
noticed a certain illogic that attends the many observa-
tions made and approaches taken to unravelling this prob-
lem. We are especially struck by the errors in logic that
confuse information relevant to cause, presentation and
the evaluation of interventions related to the condition.
The purposes of this paper are to draw upon our recent
work and observations in order to (1) contribute to a
clearer way of thinking about chemical sensitivity and (2)
to underscore the value of narrowing the focus of future
enquiry to observations of event-driven studies, rather
than concentrate on characterizing collections of patients
who present with chemical sensitivity which they identify
as having originated with a myriad of different exposure
events and at varying times in the past.
Work presented at the 23rd Congress on Occupational and Envi-
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Distinguishing different types of sensitivity
The different meanings of the term sensitivity are at least
partially responsible for the confusion surrounding chem-
ical sensitivity. Individuals differ in their responses to
increasing doses of a toxic substance. The underlying
causes of inter-individual variability include age, sex, and
genetic makeup; lifestyle and behavioral factors, includ-
ing nutritional and dietary factors. alcohol. tobacco and
drug use; environmental factors; and preexisting disease
(Ashford et al. 1990). In the classical, toricological use of
the word sensitivity. those individuals who require rela-
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Fig. 1 Hypothetical distribution of different types of sensitivities
as a function of dose. Cunre A is a sensitivity distribution for clas-
sical toxicity, e.g.. to lead or a solvent. Sensitive individuals are
found in the left-hand tail of the distribution. Curve B is a sensitiv-
ity distribution of atopic or allergic individuals in the population
who are sentitive to an allergen, e.g.. ragweed or bee venom.
Curve C is a sensitivity distribution for individuals with multiple
chemical sensitivities who. because they are already sensitized.
subsequently respond to particular incitants. e.g., formaldehyde or
phenol
tively lower doses to induce a particular response are said
to be more sensitive than those who would require rela-
tively higher doses before experiencing the same response
(Hattis et al. 1987). A hypothetical distribution of sensi-
tivities, that is, the minimum doses necessary to cause in-
dividuals in a population to exhibit a harmful effect, is
shown in curve A in Fi. 1. This distribution illustrates the
traditional toxicological concept of sensitivity. Health ef-
fects associated with classical diseases are seen in a sio-
nificant portion of the normal population as a result of ex-
posure to a relatively narrow range of doses; the sensitive
and resilient populations are found in the tails of the dis-
tribution. (Of course. not all toxic substances have small
variances or significant tails.) For the classically sensitive
person. avoidance of low-level exposures generally leads
to improvement, or at least to the arrest of the develop-
ment of the disease.
A second meaning of the word sensitivity appears in
the context of classical IgE-mediated allergy (atopy). The
atopic individual exhibits a reaction. whereas non-allergic
persons do not, even at the highest doses normally found
in the environment. A hypothetical sensitivity distribution
for an atopic effect is shown in curve B of Fig. 1. Aller-
gists include in the term allergy well-characterized im-
mune responses that result from industrial exposure to
certain chemicals, such as nickel or toluene diisocyanate
(TDI). Most allergists refer to such responses as chemical
sensitivity, but reserve this term for responses that have or
appear to have a distinct immunological basis. They pre-
fer to use a different term such as chemical intolerance for
non-immunological responses to chemicals.
Patients suffering from what North Americans call
multiple chemical sensitivity (MCS) (Cullen 1987) may
exhibit a third and entirely different type of sensitivity.
Their health problems often (but not always) appear to in-
volve a two-step process. The first step originates with
some acute or traumatic exposure. after which the trigger-
ing of symptoms and observed sensitivities occur at very
low levels of chemical exposure (the second step). The in-
ducing chemical or substance may or may not be the same
as the substances that thereafter provoke or "trigger" re-
sponses. (Sometimes the inducing substance is described
as "sensitizing" the individual, and the affected person is
termed a "sensitized'' person.) Acute or traumatic expo-
sures are not always necessary. Repeated or continuous
lower-level exposures may also lead to sensitization. To
date, there is no clear consensus on this staging process in
the scientific community.
These "sensitized individuals" are not those on the tails
of a normal distribution. They are thought to make up a
distinct subset of the population. The fact that normal per-
sons do not experience even at higher levels of exposure
those symptoms that chemically sensitive patients de-
scribe at much lower levels of exposure probably helps
explain the reluctance of some physicians to believe that
the problems are physical in nature. To compound the
problem of physician acceptance of this illness. multiple
organ systems may be affected. and multiple substances
may trigger the effects. Over time, sensitivities seem to
spread, in terms of both the types of triggering substances
and the systems affected (Randolph 1962).
Avoidance of the offending substances is reported to be
effective but much more difficult to achieve for these pa-
tients than for classically sensitive patients because symp-
toms may occur at extremely low levels and the exposures
are ubiquitous. Adaptation to chronic low-level exposure
with consequent "masking" of symptoms is alleged to
make it exceedingly difficult to discover these sensitivi-
ties and unravel the multifactorial triggering of symptoms
(Ashford and Miller 1991). A hypothetical sensitivity dis-
tribution for a single symptom for the already chemically
sensitive person in response to a single substance trigger
is shown in curve C of Fig. 1. It should be emphasized
that individuals who become chemically sensitive may
have been exposed to an initial priming event that was
toxic (e.g.. neurotoxic) as classically defined. Conceiv-
ably, exposure to certain substances. such as fonnalde-
hyde, might elicit all three types of sensitivities.
Mechanisms to explain this third type of chemical sen-
sitivity range from psychological to physiological - in-
cluding neurological, immunological. and biochemical (or
endocrinological) pathways (Ashford and Miller 1991).
Odor conditioning, perhaps involving both psychological
and physiological mechanisms, has also been suggested
(Doty et al. 1988). For reviews of the North American lit-
erature on proposed mechanisms, see Ashford and Miller
1991; Sparks et al. 1994.
Subsequent to our review of the literature on low-level
chemical sensitivity (Ashford and Miller 1991). one of us
directed an investigation of low-level chemical sensitivity
in nine European countries for the European Union (Ash-
ford et al. 1995) and the other, in the largest study of
chemically sensitive persons reported to date, compared
the features of two groups with chemically distinct. but
well-documented exposures preceding onset of self-re-
ported chemical sensitivity.
In an attempt to define the population of interest in the
European study, a multinational group of investigators
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formulated the following taxonomy to guide its data col-
lection activities and analysis. Chemical sensitivity en-
compasses three relatively distinct categories:
(I) The response of normal subjects to known exposures
in a traditional dose-response fashion. This category in-
cludes classical allergy or other immunologically-medi-
ated sensitivity.
(2) The response of normal subjects to known or un-
known exposures, unexplained by classical or known
mechanisms. This category includes:
(a) Sick building syndrome in which individuals respond
to known or unknown exposures but whose symptoms re-
solve when they are not exposed to the building.
(b) Sensitivity, such as that induced by toluene diiso-
cyanate (TDI), which begins as specific hypersensitivity
to a single agent (or class of substances) but which may
evolve into non-specific hyper-responsiveness described
in category 3 below.
(3) The heightened, extraordinary, or unusual response of
individuals to known or unknown exposures whose symp-
toms do not completely resolve upon removal from the
exposures and/or whose "sensitivities" seem to spread to
other agents. These individuals may experience: (a) a
heightened response to agents at the same exposure levels
as other individuals; (b) a response at lower levels than
those that affect other individuals: and/or, (c) a response
at an earlier time than that experienced by other individu-
als.
The European investigation focused primarily on cate-
gories 2b and 3 above. This focus essentially excluded
traditional sick building syndrome, although hypersensi-
tive sub-cohorts of individuals affected in tight buildings
(that is, those individuals who might not have recovered.
but who experienced subsequent sensitivities) were thought
to constitute a potentially useful group who could provide
important information on low-level chemical sensitivity
(Chester and Levine 1994).
Separating cause and effect: distinguishing causes,
effects and the results of inteentions
In researching the presentation and characterization of
low-level chemical sensitivity, it is useful to distinguish
contrasting ways in which observations might be
recorded. First, physician reports of individual patients
can be examined. Since chemical sensitivity was first
"discovered" by observant physicians. this might seem
like a useful place to start, but there are difficulties with
this approach. While physician reports contain much in-
formation about the patient's symptoms and complaints,
they usually contain inadequate information about possi-
ble initiating exposures or events and outcomes of various
interventions-both clinical and non-clinical. Moreover,
information differentiating initiating events/exposures
from subsequent sensitivities is often lacking or conceptu-
ally muddled. Since the precise nature of and mechanisms
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for chemical sensitivity remain ill-defined, information on
possible initiating factors and effective interventions is
crucial to improving our understanding of this somewhat
bewildering condition. Also, each of the more prevalent
effects can be caused by a multitude of biological mecha-
nisms and environmental exposures. Therefore. the symp-
toms do not indicate the nature of the causality, which
may be multifactorial.
Most physicians do not usually obtain occupational or
environmental histories on their patients. and the patients
themselves may not be fully aware of possible precipitat-
ing events or exposures. Moreover, physicians approach
patients with their own disciplinary orientations and bi-
ases, making it difficult to compare reports on individual
patients from different physicians. (Of course, different
patients with their on convictions about the cause of
their condition may also influence their physician's diag-
nosis.) For example. pulmonary physicians will tend to
focus on respiratory symptoms and airborne contami-
nants. perhaps overlooking or discounting the more sub-
jective (and possibly equally bothersome) central nervous
system (CNS) complaints. Indeed, chemically-sensitive
patients often go from physician to physician. acquiring
different diagnoses and labels - from organic brain syn-
drome to chronic fatigue syndrome to psychosomatic dis-
ease. Since there seems to be few proven effective med-
ical interventions for these patients, the eventual outcome
of the condition and possible success of various interven-
tions (such as avoidance, food rotation. or simply just let-
ting time pass) may not be known to the diagnosing physi-
cian or clinic.
Finally. isolated case reports suffer from being symp-
tom/syndrome-focused in patients with health problems
that might be induced by a wide variety of different initi-
ating exposures or events. This has compounded the diffi-
culty in understanding the origins of chemical sensitivity.
We have earlier suggested that low-level chemical sensi-
tivity might be more correctly described as a class of dis-
orders, like infectious diseases, the members of which
may present with similar symptoms, but whose different
causes and pathways need to be particularized to success-
fully address them. The different forms of chemical sensi-
tivity may be differentially precipitated by psychosocial
events or stress. or by different physical or chemical ex-
posures. The presenting symptoms - whether objective or
subjective - are not necessarily indicative of etiology.
Causes, symptoms. and interventions can each be char-
acterized as physiological (P) or psychological (). Both
physiological and psychological stressors can precipitate
either physiological or psychological symptoms, or both.
Psychological interventions (such as biofeedback and so-
cial support) can alleviate some aspects of physical dis-
ease. Neither the nature of symptoms, nor the successes of
interventions. are dispositive of the origins of a condition.
Schematically. the three factors - causes. symptoms. and
interventions - can be represented as separate "dimen-
sions" of illness (Fig. 2). Physicians and researchers may
operate in different "quadrants." For example. a physician
may believe that the cause of a particular patient's chemi-
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Fig. 2 Schematic representation of the three dimensions of illness
cal sensitivity is physiological. observe CNS (psychologi-
cal) symptoms, and treat with biofeedback or other coping
(i.e., psychological/behavioral) interventions. In contrast.
a researcher may assume stress as the "cause." observe
asthma as a consequence. and investigate the use of new
drugs to alleviate the symptoms.
What is disappointing in much of the literature is the
continuing failure to distinguish causes and symptoms of
the condition and unjustified conclusions drawn from suc-
cesses or failures of possible interventions. Although lip
service is given to making these distinctions. at the end of
the day, the failure to find consistent objective markers of
disease (Simon et al. 1993) or the finding of a history of
childhood abuse in some patient groups (Staudenmayer et
al. 1993) lead the authors to lean very heavily in the di-
rection of psychogenic causes and the recommendation of
psychological interventions, rather than physiologic
causes and the avoidance of future exposures as a treat-
ment modality. Even a recent review of some of the liter-
ature on low-level chemical sensitivity (Sparks et al.
1994), while acknowledging the multifactorial origins of
this condition, ends up recommending psychological in-
terventions as the only acceptable treatment modality.
Inasmuch as great uncertainty continues to characterize
this condition, these views are premature and perhaps
even harmful to patients (Miller 1995b).
Empirical approaches to unraveling the mysteries
of low-level chemical sensitvity
The need to distinguish information that might elucidate
causes, presentation and the success of interventions hav-
ing been discussed above. physicians' observations may
be more helpful when: 1 ) the physician sees a large num-
ber of chemically-sensitive patients. takes a complete ex-
posure history; and recognizes subgroups that give clues
to different origins and successful interventions of each:
(2) the physician happens to see a group of patients who
have experienced the same or similar events or exposures.
such as living in the same neighborhood or apartment
building or using the same type of product. such as new
carpets; (3) the physician specializes in occupational or
environmental medicine and sees patients with similar ex-
posures, occupations. or environmental histories: or (4)
the physicians are specialists - for example, pulmonary or
ear. nose and throat physicians - who concentrate on spe-
cific organ systems and are more likely to recognize sub-
sets of patients who present with problems uncharacteris-
tic of the majority of patients with the same illness. For
example, patients whose asthma is precipitated by per-
fumes, detergents, and clothing stores may constitute a
chemically-sensitive subgroup of special interest. In order
for these types of fortuitous observations to provide clari-
fication of chemical sensitivity. the occurrence of some of
the different presentations of chemical sensitivity would
have to be reasonably large.
Perhaps more informative would be observations on
the natural history of chemical sensitivity associated with
particular incidents or exposure events rather than isolated
case reports. Event-driven information includes both (1)
disease or symptom outbreaks in particular communities.
buildings, workplaces, or occupational groups and (2)
events/scenarios reported as related to chemical exposures
commonly found in certain occupations and those from
particular building materials, consumer products. anes-
thetics, and ethical drugs. Studies of collected case reports
or multiple case reports linked to specific incidents or ex-
posure events might be particularly useful. Identification
of events or exposures that could be followed over time
may be more likely to be reported by public. environmen-
tal, or occupational health authorities. compensation or
disability agencies, affected individuals. trade unions. and
patient associations rather than by physicians. While ret-
rospective investigations may be helpful, prospective
studies (for example of greenhouse workers or occupants
of newly-renovated office buildings) might yield useful
perspectives, especially if the cohort is followed for a suf-
ficiently long period of time.
We have previously cautioned about the necessity of
accounting for adaptation or the masking of symptoms in
observing the symptoms of patients with alleged low-
level chemically sensitivity. the possible confounding of
observations resulting from the use of therapeutic drugs.
and the failure to investigate food intolerances in patients
with possible low-level chemical sensitivities (Ashford
and Miller 1991). Researchers and clinicians who ignore
these concerns, and then find no consistent markers.
symptoms, or success in chemical avoidance can not
rightfully claim to have tested or investigated the many
hypotheses suggested for this condition (Datta 1993).
Recent empirical work on event-driven observations
Miller and Mlitzel (1995) recently completed a study in
which they compared features of chemical sensitivity re-
ported by two groups with chemically distinct but well-
documented exposures preceding onset of self-reported
chemical sensitivity - one group (n = 37) initially exposed
to an organophosphate or carbamate cholinesterase-in-
4------ 11  -- I
hibiting pesticide (OP), and the other (n = 75) to remodel-
ing of a building (RE). As opposed to chemical sensitivity
patients with lifelong symptoms, these individuals re-
ported becoming ill at a discrete point in time, and most
were working full-time at the time of their exposure. It
w.as felt that these two subgroups of patients should be
better able to distinguish which symptoms were or were
not related to the condition. In addition, OP and RE expo-
sure groups were chosen because: (1) Many chemical sen-
sitivity patients have reported one of these exposures as
initiating their condition; (2) such exposures are likely to
be readily identifiable: (3) pesticide spraying and building
remodeling occur at discrete times, unlike protracted ex-
posures of industrial workers to solvents; and (4) group
differences. if present, should be due to differences in po-
tency of the chemical compounds allegedly inducing the
illness.
Individuals with self-reported chemical sensitivity
were recruited via announcements in chemical sensitivity
patient newsletters to ensure a sample of strictly self-iden-
tified chemical sensitivity respondents. Respondents were
sent a mail-out/mail-back questionnaire which covered
the exposure event, a brief medical history, and physical
and cognitive symptoms occurring since their exposure.
Two hundred-three questionnaires out of 379 mailed were
returned (54%). To be included in the OP group. respon-
dents had to report having developed chemical sensitivity
as a consequence of a pesticide exposure, specify the
month and year of exposure. and provide the name(s) of
the organophosphate or carbamate pesticide(s) to which
they had been exposed. To be included in the RE group,
respondents had to report having developed chemical sen-
sitivity as a consequence of exposure to remodeling of a
building and specify the year and month in which the ex-
posure occurred or began. Those who attributed their ill-
ness to both remodeling and organophosphate exposure or
did not specify a cause were not included. since the pur-
pose was to compare two groups of chemical sensitivity
patients that identified distinctly different initiating
events.
Questionnaires contained items pertaining to the cir-
cumstances of the exposure. checklists for 98 common in-
halants and 46 common ingestants, severity ratings for
114 symptoms. questions concerning disability and qual-
ity of life issues. and the number and types of physicians
consulted. Thirty-seven questionnaires qualified for inclu-
sion in the OP group and 75 in the RE group. Completed
surveys were received from 33 states and 3 foreign coun-
tries. Nearly four times as many females as males re-
turned surveys. There were no statistically significant dif-
ferences between OP and RE group means for age, educa-
tion. years elapsed since exposure. or for gender ratios.
The average time between exposure and survey comple-
tion was 7.7 years. Average age at onset of illness was 40
vears.
OP exposures occurred in the workplace in 16 cases
(43%). home in 20 cases (54%), and during outdoor recre-
ation in I case. Proportionately more remodeling expo-
sures occurred at work (51 cases, 68%) versus home (24
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cases, 32%). Twenty-one OP respondents implicated a
single pesticide, while 16 described mixed pesticide expo-
sures. Organophosphates or carbamates most frequently
named were chlorpyrifos (19), diazinon (9), malathion
(6). and carbaryl (4). Although REs were not asked
whether new carpeting was laid during the remodeling ex-
posure. 59% mentioned new carpeting in their narrative
descriptions. In response to an open-ended question con-
cerning the exposure event. OPs reported neurological
and cardiac symptoms as their earliest symptoms approx-
imately twice as frequently as REs. and REs cited mucous
membrane irritation and headache approximately twice as
frequently as OPs.
Respondents were asked to identify their current. sin-
gle most troublesome exposure. Among the 112 respon-
dents, 28% reported insecticides. 18% new carpeting, and
11% perfume as their most problematic exposure.
Twenty-three (21 %) listed more than one exposure as be-
ing "worst." Four named formaldehyde and three diesel
exhaust as "worst." Only one cited cigarette smoke as
most problematic. Not unexpectedly, insecticides were
cited by 68% of OP respondents. while building-related
exposures (carpet. paint, varnish) were cited by 381% of
RE respondents as their worst exposure. None of the OP
respondents rated building-related exposures as "worst,"
but five of the RE respondents rated insecticides as caus-
ing the most difficulty for them at the time of the survey.
Symptom severity ratings were compared (1) on the
basis of eight factored scales and (2) on the basis of symp-
toms heuristically selected for their discreetness and fre-
quency in chemical sensitivity patients. An overall multi-
variate F-test of the eight factored scales was significantly
different for the groups for exposure type (p < 0.008) but
not for gender. None of the covariates (age. education.
years since exposure) originally fit with the model was
statistically significant. and all were dropped.
All symptom severity scale means were higher (more
severe) for the OP than the RE roup (Table 1). Based on
univariate analyses of variance. symptom severities dif-
fered significantly between OPs and REs on five of the 8
factored scales: Neuromuscular. affective, airway, gas-
trointestinal, and cardiac symptoms were rated as more
severe by OPs than REs. Muscle-related symptoms bor-
dered on significance, with OPs higher than REs. Cogni-
tive and head-related symptoms were not significantly
different between the two groups. Notably, for both
groups. cognitive symptoms attained the highest mean
severity, while the largest inter-group difference occurred
for cardiac symptoms. Presumably, cognitive symptoms
cause the most difficulty for these respondents. Airway
symptoms were sigrnificantly more severe for OPs than
REs, a finding that was not expected because of the rela-
tively strong association between reports of airway prob-
lems and SBS. but not low-level OP exposure.
The finding that pesticide-exposed respondents report
similar. but much more severe symptoms than remodel-
ing-exposed respondents is consistent with prior anecdo-
tal observations. and supports the hypothesis that some bi-
ological mechanism is operative. If underlying depres-
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Table 1 Comparison of Mean (SD) severity of symptom scales in
chemical sensitivity exposure groups
Symptom scale Organo- Remodeling p <
phosphate
Neuromuscular 12.9 (7.5) 9.0 (6.5) 0.007
Head-related 15.9 (7.6) 13.4 (8.3) 0.12
Muscle-related 17.5 (8.8) 14.2 (8.7) 0.06
Affective 17.7 (7.3) 13.0 (6.8) 0.001
Airway 14.9 (7.5) 12.0 (6.5) 0.04
Cognitive 18.0 (8.3) 15.8 (7.7) 0.17
Gastrointestinal 15.3 (7.9) 11.1 (8.4) 0.01
Cardiac 16.5 (8.2) 9.9 (9.0) 0.001
Fifteen most frequent
symptoms 20.8 (6.2) 16.7 (6.0) 0.003
sion. somatoform disorder, or other psychological factors
were the primary cause of chemical sensitivity, one would
expect to see no difference between the OP and RE
groups in terms of symptom severity (for a more complete
discussion of this point, see Miller and Mitzel 1995). A
threat to the validity of these findings remains that of sam-
pling from preexisting groups. a difficulty always present
with retrospective studies. For example. the OP group
might be over-reporting symptoms relative to the RE
group because organophosphate exposure is more specific
and involves a known neurotoxin, while the RE group at-
tributes illness to building remodeling, which most people
consider benign. In order to explain the findings in this
study. such a cognitive hypothesis would require that pa-
tients hold powerful beliefs regarding the health impact of
pesticide versus remodeling exposures that permeate both
their symptom reports and their ideas as to which in-
halants and ingestants trigger symptoms. While possible,
this explanation seems less parsimonious than the one of-
fered here.
The European investigation
Three teams of investigators recently completed a study
of chemical sensitivity in Europe (Ashford et al. 1995).
The purpose of their investigation was to explore the exis-
tence and nature of chemical sensitivity in nine selected
countries. No prior systematic study of the occurrence or
magnitude of chemical sensitivity had been undertaken in
any European country, and there were no case definitions
or agreement on the criteria for diagnosis of the condition.
However. it was thought that cross-country studies might
yield fresh insights into the problem which appears to be
influenced by a number of social and cultural factors. In
the United States, where chemical sensitivity has received
the most attention, some of these social and cultural fac-
tors have. to varying degrees. hindered study and under-
standing of this problem: Partisan biases among physi-
cians concerning the etiology and relevance of chemical
sensitivity: disagreements with respect to who should pay
for diagnosis and treatment; chemical manufacturers'
concerns about liability: the presence of well-informed.
networked and activated patient groups and a citizenry
with an acute awareness of and concern for environmental
exposures. Not all of these factors are present to the same
degree in Europe. Therefore, it was felt that a cross-coun-
try investigation in Europe might provide a fresh perspec-
tive on the subject, as well as afford an opportunity to ex-
amine differences between countries in terms of their pat-
tern and use of various chemicals. building construction
and ventilation practices and differing traditions of occu-
pational and environmental medicine.
The study was not designed to test any specific hy-
pothesis, but to collect and compare information from
several countries that might suggest hypotheses for future
research. Definitive conclusions about the nature and eti-
ology of chemical sensitivity were not sought. Following
similar protocols, three teams collected data and reported
findings: Denmark. Finland. Norway. Sweden. and the
United Kingdom (Team A): Belgium. Germany. and the
Netherlands (Team B): and Greece (Team C). A comput-
erized literature search was undertaken and persons
thought likely to have some knowledge or experience
with chemical sensitivity. including ministries of environ-
mental or public health. environmental groups. labor
unions. and professional medical associations were con-
tacted and interviewed according to general guidelines.
Anecdotal clinical observations and non-peer-reviewed
"gray" literature reports were included in the analysis for
the additional insights and opportunities they might pro-
vide for future study.
Despite the potential usefulness of exposure or event-
driven information. the research teams were unable to dis-
cover many situations or incidents that could provide use-
ful data relevant to chemical sensitivity as defined above.
There is no paucity of events or exposures: there is simply
little information available about the outcomes in terms of
the development of chemical sensitivity. Information on
the temporal features of the development and disappear-
ance/waning of the problems would be very important,
but was very difficult to obtain. A variety of factors may
explain this relative lack of information. For example, the
research tended to focus on physicians and the medical lit-
erature as sources of data. In general, physicians interact
with individual patients and have little reason (and per-
haps interest) to recognize that their patient may be part of
a larger group of individuals who have experienced a
common exposure or event. Second, physicians. re-
searchers. and health authorities who are involved in
events or exposure situations (e.g., a "sick building" or
exposures at a particular workplace/occupation) do not
likely have a focus on chemical sensitivity and thus have
little reason to: (1) follow the affected individuals for long
periods of time; (2) identify subsequent sensitivities; or
(3) distinguish between initiating and subsequent trigger-
ing exposures. Despite this. the research teams did iden-
tify some exposure or event-driven information that may
be suggestive of low-level chemical sensitivity.
The predominant loci of the alleged initiating expo-
sures/events in this investigation were industrial, office,
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Table 2 Some exposures reported as associated with the onset of chemical sensitivity in Europe
Exposure Denmark Sweden Norway Finland Germany Holland Belgium U.K. Greece
Amalgam/mercury , , /
.-\nesthetic agents /
Carpets and glue/ ,
Diesel exhaust ,
Formaldeh-yde , 
Hairdressing chemicals / , /
Indoor climate ,/ 
Industrial deareasers /
Methyl methacrylate ,/ /
New/renovated buildings / / 
Organic solvents / / , , / ,/ / ,/
Paints/lacquers / / /
Pentachlorophenol/wood preservative , , ,
Pesticides ,/ / / / / 
Pharmaceuticals , ,
Printed material ,/ 
Stress/psychosocial factors / / , /
and domestic environments. Agricultural exposures re-
sulting in chemical sensitivity were mentioned in several
countries. Hairdressers comprised an occupational group
that appeared to be affected in several countries.
A relatively small number of substances were specifi-
cally associated with the onset of chemical sensitivity
(Table 2). The substances most often mentioned as initia-
tors included pesticides, solvents, paints and lacquers, and
formaldehyde. Repeated or continuous low-level expo-
sure. rather than a single event, characterized most of the
experience. Psychosocial stressors were also mentioned as
initiating chemical sensitivity.
A unique situation was reported in Germany, where ex-
posure to emissions from treated wood has been associ-
ated with its own clinical entity-wood preservative syn-
drome (or pentachlorophenol syndrome) (Schimmelpfen-
nig 1994). Some individuals exposed to wood (or rooms
with wood) treated with pentachlorophenol (PCP) and lin-
dane (contaminated with dioxins and furans, and dis-
solved in solvents at a concentration of about 5%) have
experienced the multitude of symptoms commonly asso-
ciated with chemical sensitivity. These include immuno-
logic. dermatologic, neurologic, psychiatric, endocrino-
logic. and ophthalmologic symptoms (Huber et al. 1992).
Many of the physicians surveyed in Germany reported
that pentachlorophenol and wood preservatives initiated
illness and described subsequent sensitivities (e.g., to
odors. solvents. and. sometimes, foods) in their patients.
While these investigations were neither exhaustive nor
comprehensive. nevertheless, some interesting observa-
tions can be made. Pesticides, organic solvents, formalde-
hyde. and stress were mentioned as causes of chemical
sensitivity in many countries. while anesthetic agents
were mentioned repeatedly only in Greece. Problems with
hairdressing chemicals were mentioned in Denmark, Swe-
den. and Greece. Of course, the categories "organic sol-
vents" and "pesticides" are overly-broad. Identification of
more specific substances in these categories would be
more informative. However, in many cases, more defini-
tive information simply was not available. With the ex-
ception of pentachlorophenol, these are the same sub-
stances associated with the onset of chemical sensitivity
in North America (Ashford and Miller 1991).
A much larger number of chemically-diverse sub-
stances were reported to trigger symptoms in persons who
were already alleged to be chemically sensitive. These
parallel the "triggers" frequently reported in the United
States and include perfumes, detergents and cleaners,
smoke, cooking odors, car exhaust, new clothing, nail pol-
ish, newspaper print, etc. Reactions to these substances
were reported in each country. Symptoms frequently in-
clude: Mucous membrane irritation. gastrointestinal com-
plaints, joint pain, respiratory complaints, such as chest
tightness and rhinitis. fatigue, and central nervous system
problems, such as headache, dizziness. memory loss. and
difficulty with concentration. Physicians reported a higher
occurrence of symptoms associated with chemical sensi-
tivity among women in the age group 30-50 in Scandi-
navia. Germany, and Greece.
Comparison of European
and North American experiences
with low-level chemical sensitivity
The limited data available at this time from North Amer-
ica and Europe suggest that low-level chemical sensitivity
is not a single. distinct clinical entity. Clinical presenta-
tions are extraordinarily diverse, a major reason why con-
sensus on a case definition for the illness has been so dif-
ficult to achieve despite numerous attempts (Miller
1994a). Symptoms appear to involve any and every organ
I-----I I- ~- I -
374
system or several systems simultaneously. although cen-
tral nervous system symptoms such as fatigue, mood
changes (irritability, depression). and memory and con-
centration difficulties predominate. Even among persons
who have shared the same initiating exposure. symptoms
and severity differ markedly. Ultimately. chemical sensi-
tivity may be more accurately characterized as a class of
disorders. like infectious diseases, which share a common
general mechanism, yet within the class, particular mem-
bers may involve different symptoms, agents, and specific
mechanisms.
From European and North American observations, a
wide range of environmental exposures appear able to ini-
tiate the problem. While implicated chemicals are struc-
turally diverse, certain ones appear again and again on
both continents:
1. Pesticides are frequently cited in North America and
Europe, with the exception of Sweden. Finland, and the
Netherlands, where indoor use of pesticides may be less
frequent as a consequence of cooler temperatures and re-
duced insect populations. Organophosphate and carba-
mate pesticides are those most often reported as causing
illness in the United States, but this may simply reflect the
fact that these are among the agents most commonly ap-
plied. The greater symptom severity reported by chemical
sensitivity patients exposed to organophosphates versus
remodeling, summarized earlier in this paper, suggests
that some compounds in this class might be especially po-
tent sensitizers, at least for a subset of the population.
2. Organic solvent exposure was cited in every European
country surveyed and is commonly cited in North Amer-
ica. Such exposures frequently occur in the workplace and
are more often chronic than acute in nature.
While there are consistent observations regarding causes
of chemical sensitivity between continents. there are also
notable differences, for example, the so-called 'wood
preservative syndrome" associated with pentachlorophe-
nol use in Germany.
Although SBS is widely recognized in the Scandina-
vian countries where a number of internationally-known
researchers are engaged in its study, instances of sick
building syndrome per se did not generally reveal chemi-
cally sensitive subgroups. Conceivably. preoccupation
with immediate effects may have obscured their discov-
ery. Certainly, there was no indication of a large problem
in those instances. Initiating experiences with carpets
were noted, however. If future inquiry were to reveal that
chemical sensitivity does not occur in even a subset of in-
dividuals in European SBS episodes, this finding might
suggest the iportance of ther factors for example. thep
use of wall-to-wall carpeting (common in the United
States and relatively infrequent in Europe). or use of cer-
tain fragrances, air fresheners. cleaners. and/or extermina-
tion practices.
In both Europe and North America. patients report
spreading of their sensitivities to an array of common ex-
posures, including fragrances. cleaning agents. engine ex-
haust, alcoholic beverages. foods. and medications the
formerly tolerated without difficulty. The fact that mar
of these individuals voluntarily forego pizza. chocolat
beer. or other favorite foods because they make them fe,
so ill warrants consideration - there is little secondar
gain to be garnered from such forbearance. Many partic
pants in the North American study reported that drugs. ir
gestants containing chemical additives (monosodium gIL
tamate, chlorinated tap water), and food-drug combine
tions (alcoholic beverages or xanthine-containing foods
made them, ill. a finding consistent with a hypothesis the
these individuals exhibit amplified responses to pharma
cologic doses of a variety of substances (Bell et al. 1992;'
Generally speaking. awareness of chemical sensitivity
may be greater in countries with more environmental ac
tivism. but illnesses resembling chemical sensitivity wert
described in every country that was studied. Clinical ecol-
ogy's origins in the United States and its spread to other
English-speaking nations, including Canada and the
United Kingdom. no doubt have influenced the numbers
of patients receiving a diagnosis of chemical sensitivity in
those countries. Discord among physicians as to what
constitutes appropriate diagnostic and therapeutic ap-
proaches in these countries permeates professional meet-
ings. medical journals. and court proceedings. Where pa-
tients must "prove" a particular exposure caused their ill-
ness in order to receive worker's compensation or reim-
bursement for medical expenses (as in the United States
where there is no national health care system). disputes
between medical practitioners (who may testify on oppos-
ing sides) are most contentious.
Cultural practices may affect the prevalence of chem-
ical sensitivity. In some European countries, people typ-
ically spend several hours each day out-of-doors. for ex-
ample. walking to work or shopping, and windows in
homes and offices may be left open part or most of the
day. In contrast. on average. Americans spend 90% or
more of the day indoors, often in tightly-sealed struc-
tures. where levels of certain volatile organic air conta-
minants can be orders of magnitude higher than out-of-
doors.
Choices of building construction materials and furnish-
ings also vary greatly between countries, including use of
wall-to-wall carpeting versus washable throw rues or no
floor coverings at all: solid hardwood furnishings versus
particle board or pressed wood: paint. wallpaper. and ad-
hesive constituents: office equipment. including photo-
copiers and computers. etc.
Ventilation practices may be similarly diverse. Tightly-
constructed buildings with little fresh make-up air built in
North America since the oil embargo of the mid 1970's
could be a factor that explains the apparent increase in
chemical sensitivity cases over the past two decades in the
United States and Canada. The experience with SBS. but
not chemical sensitivity. in Scandinavia merits closer ex-
amination to determine whether the latter condition has
thus far escaped attention or whether environmental or
perhaps genetic or cultural differences may prevent devel-
opment of the condition.
(1_ _____ _I
Use of chemicals also varies from country to country,
in particular. pesticides, cleaners, and personal care prod-
ucts. including fragrances. Comparing differing rates of
consumption of these products, as well as pharmaceuti-
cals. and the incidence of chemical sensitivity among
,countries, could provide further clues.
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of-the-art immunological testing or other sophisticated
tests, and that compare adequate numbers of patients and
controls, will be costly. Funding agencies will need to in-
vest adequate sums to acquire answers in this area as they
have for other diseases, such as breast cancer and AIDS.
Until sufficient research funds become available, chemi-
cal sensitivity no doubt will continue to pit physician
against physician. perplex policy makers. and impoverish
patients and corporations alike.
Complex questions concerning the origins and mechanisms
of chemical sensitivity will not be resolved by retrospec-
tive survey studies. indeed, probably not by retrospective
studies of any kind. Perhaps more informative would be
prospective observations on the natural history of chemical
:ensitivity associated with particular incidents or exposure
events rather than isolated case reports. Nevertheless. en-
lightening similarities and instructive differences can be
gleaned from future. more directed cross-country compar-
isons of experiences with chemical sensitivity.
In the past five years in the United States, controver-
sies surrounding chemical sensitivity have exploded far
bevond the narrow confines of a medical debate into a na-
tional debate with far-reaching policy and regulatory im-
plications. Most recently, a number of U.S. Persian Gulf
-veterans have reported multi-system health problems and
new-onset intolerances to chemicals. foods, and other
substances since returning from the war (Miller 1994b).
Some have received a diagnosis of chemical sensitivity
from private physicians and now seek medical care and
compensation for the condition. Such trends in North
America could be mirrored in European countries over the
next few decades.
Understanding chemical sensitivity is pivotal to estab-
lishing sound environmental policy. If there is a subset of
the population that is (or can become) especially sensitive
to low-level chemical exposures, a strategy for protecting
this subset must be found. If it were to be determined that
certain chemical exposures can lead to sensitization. then
perhaps these exposures could be avoided. Perhaps by pre-
venting chemical accidents, prohibiting occupancy of
buildings prior to finish-out or completion. avoiding use of
certain cholinesterase-inhibiting pesticides indoors. etc..
society could protect more vulnerable individuals from be-
coming sensitized in the first place. It would make little
sense to regulate chemicals at the parts per billion level or
lower if what was required was to keep people from be-
coming sensitized in the first place. Indeed, by under-
standing the true nature of chemical sensitivity and who is
at risk. we may prevent unnecessary and costly overregu-
lation of environmental exposures in the years to come.
Chemical sensitivity could be a new paradigm that has
the potential to explain many chronic and costly illnesses.
including fatigue. depression, headaches. and asthma. or it
could continue to elude definition. Not understanding
chemical sensitivity, we take an immense gamble. But
knowledge will not come cheaply. Future studies on
chemical sensitivity that involve blinded challenges in a
controlled environment, that utilize brain imaging, state-
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